UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000037344
Receipt No. R000042580
Scientific Title Explorative study on the effect of novel training program on visual perceptual dysfunction of schizophrenia
Date of disclosure of the study information 2019/07/12
Last modified on 2019/07/12 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Explorative study on the effect of novel training program on visual perceptual dysfunction of schizophrenia
Acronym Explorative study on the effect of novel training program on visual perceptual dysfunction of schizophrenia
Scientific Title Explorative study on the effect of novel training program on visual perceptual dysfunction of schizophrenia
Scientific Title:Acronym Explorative study on the effect of novel training program on visual perceptual dysfunction of schizophrenia
Region
Japan

Condition
Condition Schizophrenia
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 In this study, we develop software applying Backward Masking task, which is a neuropsychological task of visual perception.
Basic objectives2 Others
Basic objectives -Others And we will examine the feasibility, safety and tolerability as a training program aimed at enhancing neurocognition of schizophrenia.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes cognitive function: BACS, BVMT-R, FEST (baseline, pre-training, post-training, follow up)
Key secondary outcomes psychiatric symptoms: PANSS (baseline, pre-training, post-training, follow up)

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Training was conducted over 6 weeks and included 20 sessions of 3 different VBM tasks. Two training tasks involved letter identification; one with a mask of overlapping X's that spatially coincided with the target (T1) and one with a non-overlapping mask (T2). The third task (T3) presented a circle in one of four locations followed by a mask with 3 X's in all four locations, and required the user to determine the target circle's location.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >=
Gender Male and Female
Key inclusion criteria Participants were people with schizophrenia or schizoaffective disorder, and the medication was not changed from 6 months prior the baseline assessment.
Key exclusion criteria Exclusion criteria were premorbid IQ lower than 70, substance abuse in the last 6 months, history of neurological illness or injury, corrected visual acuity worse than 20/30, clinically unstable .
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Satoru
Middle name
Last name Ikezawa
Organization National Center of Neurology and Psychiatry
Division name National Center Hospital
Zip code 187-8551
Address 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, JAPAN
TEL 042-341-2711
Email satoru.ikezawa@ncnp.go.jp

Public contact
Name of contact person
1st name Satoru
Middle name
Last name Ikezawa
Organization National Center of Neurology and Psychiatry
Division name National Center Hospital
Zip code 187-8551
Address 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, JAPAN
TEL 042-341-2711
Homepage URL
Email satoru.ikezawa@ncnp.go.jp

Sponsor
Institute National Center of Neurology and Psychiatry
Institute
Department

Funding Source
Organization The Japan Society for the Promotion of Science (JSPS)
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Center of Neurology and Psychiatry
Address 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, JAPAN
Tel 042-341-2711
Email rinri-jimu@ncnp.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 8
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2016 Year 02 Month 09 Day
Date of IRB
2016 Year 04 Month 01 Day
Anticipated trial start date
2016 Year 04 Month 01 Day
Last follow-up date
2021 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 07 Month 12 Day
Last modified on
2019 Year 07 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042580